Table 1.

Healthy People 2020 CKD objectives

Goal No.Stated GoalImprovement Sought, %
CKD-1Reduce the proportion of the United States population with CKD10
CKD-2Increase the proportion of persons with CKD who know that they have impaired renal function4
CKD-3Increase the proportion of hospital patients who incurred AKI who have follow-up renal evaluation in 6 mo postdischarge10
CKD-4.1Increase the proportion of persons with CKD who receive medical evaluation with serum creatinine, lipids, and microalbuminuria10
CKD-4.2Increase the proportion of persons with type 1 or 2 diabetes and CKD who receive medical evaluation with serum creatinine, microalbuminuria, A1c, lipids, and eye examinations10
CKD-5Increase the proportion of persons with diabetes and CKD who receive recommended medical treatment with ACEIs or ARBs10
CKD-6.1Reduce the proportion of persons with CKD who have elevated BPMinimal statistical significancea
CKD-6.2Increase the proportion of adults ages ≥50 yr old with CKD who currently take statins to lower their blood cholesterolMinimal statistical significancea
CKD-7Reduce the number of deaths among persons with CKDTracked for informational purposesa
CKD-8Reduce the number of new patients with ESRD10
CKD-9.1bReduce kidney failure caused by diabetes10
CKD-9.2Reduce kidney failure caused by diabetes among persons with diabetes10
CKD-10bIncrease the proportion of patients with CKD receiving care from a nephrologist at least 12 mo before the start of RRT10
CKD-11.1Increase the proportion of adult patients on HD who use AVFs as the primary mode of vascular access10
CKD-11.2Reduce the proportion of adult patients on HD who use catheters as the only mode of vascular access10
CKD-11.3bIncrease the proportion of adult patients on HD who use AVFs or have maturing AVFs as the primary mode of vascular access at the start of RRT10
CKD-12Increase the proportion of patients on dialysis waitlisted and/or receiving a deceased donor KT within 1 yr of ESRD start (among patients <70 yr of age)10
CKD-13.1Increase the proportion of patients receiving a KT within 3 yr of ESRD10
CKD-13.2Increase the proportion of patients who receive a preemptive KT at the start of ESRDTracked for informational purposesa
CKD-14.1bReduce the total number of deaths for persons on dialysis10
CKD-14.2bReduce the number of deaths in patients on dialysis within the first 3 mo of initiation of RRT10
CKD-14.3bReduce the number of cardiovascular deaths for persons on dialysis10
CKD-14.4Reduce the total number of deaths for persons with a functioning KT10
CKD-14.5Reduce the number of cardiovascular deaths in persons with a functioning KT2
  • ACEI, angiotensin–converting enzyme inhibitor; ARB, angiotensin receptor blocker; HD, hemodialysis; AVF, arteriovenous fistula; KT, kidney transplant. Modified from the US Department of Health and Human Services’ Healthy People 2020: Chronic Kidney Disease (24), with permission.

  • a Details and contextualization are in the US Department of Health and Human Services’ Healthy People 2020: Chronic Kidney Disease (24).

  • b Goals that were addressed in this study.